R-Biopharm Group enters into collaboration with SSI (DK) in the field of tuberculosis diagnostics
R-Biopharm Group recently announced a collaborative agreement with SSI, focusing on discovery and development of novel diagnostic approaches for the detection of tuberculosis infection. The development of new diagnostic assays in the area of infectious diseases is a priority for R-Biopharm, a company with 30 years of experience in providing testing solutions for Clinical Diagnostics […]
